Feeds:
Posts
Comments

Posts Tagged ‘UK National Institute for Health and Clinical Excellence guidance’

URO TODAY: The UK National Institute for Health and Clinical Excellence guidance recommends conservative management of men with ‘low-risk’ localised prostate cancer, monitoring the disease using changes to PSA over time and re-biopsy. However, there is little evidence of the changes in PSA level that should alert to the need for clinical re-assessment. READ MORE> and HERE> (New Prostate Cancer Infolink)

Read Full Post »

JULY 6: NURSING TIMES.NET: UK research that found reasonably favourable results from high-intensity focused ultrasound (HIFU) treatment in 172 men with localised prostate cancer (cancer that had not spread) looks promising, but long-term studies are needed. READ MORE>

Current UK National Institute for Health and Clinical Excellence guidance advises that the evidence supports the safety and efficacy of HIFU for prostate cancer, provided that monitoring, audit and clinical governance of any procedures are carried out.

It advises that longer-term effects on survival and quality of life are unknown, and that doctors should therefore ensure that patients understand these uncertainties and the alternative treatment options.

Read Full Post »